General
Preferred name
D-glucose
Synonyms
glucose ()
Dextrose ()
Dextrose anhydrous ()
Glucose anhydrous ()
Dextrogel ()
Glucose, unspecified form ()
Dextrose, anhydrous ()
D5W ()
Rapilose ()
Dextrose component of navstel ()
ANHYDROUS DEXTROSE ()
NSC-406891 ()
Glucose, anhydrous ()
Glucose ()
Grape sugar ()
Liquid glucose ()
Glucose, alpha-d- ()
Glucose injection ()
Gambrosol ()
Dextrose, unspecified ()
Dextrose solution ()
Dextrose, unspecified form ()
Clintec ()
Yourgluco ()
Capd ()
Dextro Energy ()
Glucosum, anhydrous ()
GSF-Syrup ()
Anhydrous glucose ()
D-glucose, anhydrous ()
P&D ID
PD008964
CAS
111688-73-4
58367-01-4
9037-91-6
2280-44-6
Tags
drug
available
Drug indication
Discovery agent
hearing loss
Drug Status
approved
Max Phase
4.0
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugMAP
Guide to Pharmacology
NPC Screening Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
52
Properties
(calculated by RDKit )
Molecular Weight
180.06
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
5
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
0
cLogP
-3.22
TPSA
110.38
Fraction CSP3
1.0
Chiral centers
5.0
Largest ring
6.0
QED
0.29
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
Endogenous Metabolite
Pathway
Metabolic Enzyme/Protease
Source data
